Japanese Trade Distributors Stock News

TSE:9001
TSE:9001Transportation

Tobu Railway’s Valuation After Board Meeting Plans Dividend Forecast Revision

Board meeting puts Tobu Railway’s dividend policy in focus Tobu Railway (TSE:9001) has called an April 30, 2026 board meeting to consider revising its year end dividend forecast, a move that puts shareholder payouts and capital allocation firmly on investors’ radar. See our latest analysis for Tobu Railway. The share price has risen in the short term, with a 1 day share price return of 2.31% and a 7 day share price return of 2.97%. The 1 year total shareholder return of 9.43% contrasts with a...
TSE:7981
TSE:7981Building

Takara Standard (TSE:7981) Margin Improvement Reinforces Bullish Earnings Narratives

Takara StandardLtd (TSE:7981) has wrapped up FY 2026 with fourth quarter revenue of ¥60.1 billion and Basic EPS of ¥37.38, while trailing twelve month revenue stood at ¥252.8 billion and EPS at ¥231.88, alongside earnings growth of 35.9% over the last year. Over recent periods, revenue has ranged from ¥59.1 billion to ¥69.5 billion per quarter, with quarterly EPS moving between ¥30.28 and ¥89.68, giving investors a clear view of how the top line and per share earnings have tracked into the...
TSE:2692
TSE:2692Consumer Retailing

Itochu Shokuhin (TSE:2692) Q4 Loss And 1.1% Margin Pressure Test Bullish Narratives

ITOCHU-SHOKUHIN (TSE:2692) has wrapped up FY 2026 with fourth quarter revenue of ¥161.9b and a basic EPS loss of ¥46.35, against a trailing twelve month EPS of ¥652.09 on revenue of ¥720.2b that came with 0.8% earnings growth and a 1.1% net margin over the period. Over recent quarters, revenue has ranged from ¥175.1b in Q1 2026 to ¥192.5b in Q3 2026, while quarterly EPS has moved between ¥196.10 and ¥292.35 before the latest quarterly loss. This leaves investors to weigh a solid full year...
TSE:9110
TSE:9110Shipping

One‑Off ¥7.0b Gain Driving NS United Kaiun Kaisha (TSE:9110) Margin Story Challenges Bulls

NS United Kaiun Kaisha (TSE:9110) has just posted its FY 2026 numbers, with fourth quarter revenue of ¥58,520 million and basic EPS of ¥252.15, rounding out a year in which trailing twelve month EPS reached ¥1,022.47 on revenue of ¥229,784 million and earnings growth of 29.4%. Over the last year, the company has seen net profit margin move from 7.5% to 10.5%, while trailing twelve month net income excluding extra items reached ¥24,095 million, supported by a ¥7.0b one off gain that is front...
TSE:8103
TSE:8103Trade Distributors

Meiwa (TSE:8103) Margin Slip To 2% Tests Bullish High Quality Earnings Narrative

Latest FY 2026 Results Set the Stage for Meiwa's Next Chapter Meiwa (TSE:8103) closed FY 2026 with fourth quarter revenue of ¥43.1b and basic EPS of ¥29.85, rounding out a year where trailing twelve month revenue reached ¥164.9b and EPS came in at ¥83.98. Over recent periods, revenue has moved from ¥156.7b on a trailing basis in FY 2025 to ¥164.9b in FY 2026, while trailing EPS has shifted from ¥83.27 to ¥83.98. This gives investors a clear view of how top line and per share profitability...
TSE:2413
TSE:2413Healthcare Services

The Bull Case For M3 (TSE:2413) Could Change Following Strong FY2026 Results And Capital Return Boost

M3, Inc. held a board meeting on May 1, 2026, alongside releasing fiscal 2026 results that showed double-digit revenue and profit growth, a higher annual dividend, and new plans for share repurchases under its Articles of Incorporation. The company also issued an upbeat forecast for fiscal 2027, projecting revenue of ¥400.0 billion and profit attributable to owners of the parent of ¥53.0 billion, underscoring management’s confidence in its healthcare-related digital services model. Next, we...
TSE:3349
TSE:3349Consumer Retailing

Assessing COSMOS Pharmaceutical (TSE:3349) Valuation After Sales Growth, Steady Outlook And Higher Dividend

Why COSMOS Pharmaceutical’s latest update matters for shareholders COSMOS Pharmaceutical (TSE:3349) reported 7.7% sales growth with modest profit gains for the nine months to February 2026, maintained its full year forecast, and flagged an annual dividend increase to ¥75. See our latest analysis for COSMOS Pharmaceutical. The latest earnings and dividend news comes after a weaker period for the share price, with a 30 day share price return of 8.34% and a year to date share price return...
TSE:4221
TSE:4221Chemicals

Okura Industrial (TSE:4221) Margin Decline To 4.5% Tests Bullish Earnings Growth Narrative

Okura Industrial Q1 2026 earnings snapshot Okura Industrial (TSE:4221) opened its Q1 2026 scorecard with revenue of ¥24.0b and basic EPS of ¥130.49, setting the tone for how the year is starting at a share price of ¥4,910. Over recent quarters the company has seen revenue move from ¥21.7b in Q1 2025 to ¥22.4b in Q4 2025 and now ¥24.0b, while basic EPS has ranged from ¥108.47 to ¥130.49 over the same span. This gives a clear sense of how the top and bottom line are tracking into this latest...
TSE:7731
TSE:7731Consumer Durables

Assessing Nikon (TSE:7731) Valuation After The APDIS MV5X Laser Radar Launch

Nikon (TSE:7731) is drawing investor attention after the commercial launch of its APDIS MV5X Laser Radar system, which uses Aeva’s Eve sensor technology under a multi-year production agreement for automated inspection and metrology. See our latest analysis for Nikon. The APDIS MV5X announcement arrives as Nikon’s share price shows mixed short term momentum, with a 7 day share price return of 7.49% contrasting with a 30 day share price return decline of 8.40%. The 1 year total shareholder...
TSE:7733
TSE:7733Medical Equipment

Is FDA Clearance Of POWERSEAL Open Extended Jaw Reshaping The Investment Case For Olympus (TSE:7733)?

In April 2026, Olympus Corporation received FDA 510(k) clearance in the U.S. for its single-use POWERSEAL Open Extended Jaw Sealer/Divider, expanding its POWERSEAL surgical portfolio across multiple specialties including general, gynecological, colorectal, bariatric, urological, thoracic, and vascular surgery. This clearance broadens Olympus’s advanced energy offering with an open-surgery device designed for confident vessel sealing up to 7mm, multifunctional jaw capabilities, and ergonomics...
TSE:6135
TSE:6135Machinery

Makino Milling Machine (TSE:6135) Margin Improvement To 8% Tests Bullish Profitability Narratives

Makino Milling Machine (TSE:6135) has wrapped up FY 2026 with fourth quarter revenue of ¥71,052 million and basic EPS of ¥297.67, while trailing twelve month revenue sits at ¥261,184 million and EPS at ¥897.47. Over the past six reported quarters, revenue has ranged from ¥55,397 million to ¥71,052 million per quarter and basic EPS has moved between ¥53.32 and ¥310.67, providing a view of how the top and bottom line have tracked into the latest result. Net profit margin was reported at 8%...
TSE:4519
TSE:4519Pharmaceuticals

Do Chugai Pharmaceutical’s (TSE:4519) Strong Q1 Earnings And New Stock Plan Reframe Its Incentives Story?

Chugai Pharmaceutical Co., Ltd. reported first-quarter 2026 results with sales of ¥291,577 million, revenue of ¥321,747 million, and net income of ¥115,418 million, all higher than a year earlier. The board also moved to introduce a trust-based stock compensation system, highlighting how governance and incentive design are evolving alongside the company’s earnings profile. We’ll now examine how this strong first-quarter earnings growth shapes Chugai Pharmaceutical’s investment narrative and...
TSE:8015
TSE:8015Trade Distributors

Toyota Tsusho (TSE:8015) Margin Compression Tests Bullish Profitability Narratives

Toyota Tsusho (TSE:8015) has wrapped up FY 2026 with fourth quarter revenue of ¥3.2t and basic EPS of ¥79.13, supported by trailing twelve month revenue of ¥11.6t and EPS of ¥350.95 that frame the latest print in a broader context of steady throughput. Over the past six reported quarters, revenue has moved from ¥2.6t in FY 2025 Q3 to ¥3.2t in FY 2026 Q4, while quarterly EPS has ranged between ¥79.13 and ¥94.76, giving you a clear view of how the top and bottom line have tracked together as...
TSE:9147
TSE:9147Logistics

Is It Too Late To Consider Nippon Express Holdings (TSE:9147) After A 66% One Year Rally?

With Nippon Express Holdings catching your eye, the key question is whether the current share price around ¥4,121 reflects fair value or if the market is mispricing the stock. Recent returns have been strong, with the share price showing 8.6% over the last week, 13.8% over the last month, 21.8% year to date and 66.3% over the last year, along with 70.0% over three years and 70.5% over five years. Recent company news helps frame these moves for you, including updates around business...
TSE:9715
TSE:9715Professional Services

Transcosmos (TSE:9715) TTM Earnings Growth Of 15.5% Challenges Long‑Term Bearish Narratives

transcosmos (TSE:9715) has wrapped up FY 2026 with fourth quarter revenue of ¥100.9 billion and basic EPS of ¥71.12, setting the tone for how investors read the latest set of numbers. The company has seen quarterly revenue move from ¥95.9 billion in Q4 FY 2025 to ¥100.9 billion in Q4 FY 2026, while basic EPS shifted from ¥100.10 to ¥71.12 over the same period. This gives a clear view of how the top line and per share earnings have tracked. With trailing net margin at 3.3% versus 3.0% a year...
TSE:3941
TSE:3941Packaging

Rengo (TSE:3941) Valuation Check After Profit Guidance Cut And TRICOR Impairment Charges

What the revised guidance and TRICOR impairments mean for investors Rengo (TSE:3941) has cut its full year profit outlook, even as sales guidance stays unchanged, after weaker profitability in its European heavy duty corrugated packaging business and substantial TRICOR related impairments. The company now expects operating profit of ¥37,000 million, compared with an earlier outlook of ¥40,000 million. Profit attributable to owners of parent is now expected to be ¥21,000 million, instead of...
TSE:6501
TSE:6501Industrials

A Look At Hitachi (TSE:6501) Valuation After New ¥500,000 Million Buyback And Profit Growth Update

Why Hitachi stock is back in focus after its latest buyback and earnings update Hitachi (TSE:6501) has moved back into the spotlight after announcing a ¥500,000 million share repurchase program alongside its full year 2026 results, linking capital returns with recently reported profitability. See our latest analysis for Hitachi. The share repurchase and earnings update have arrived after a mixed stretch for the stock, with a 7 day share price return of an 8.3% decline and a year to date share...